Biohaven Ltd.

Direct answer

Biohaven Ltd. is publicly traded on NYSE under the ticker BHVN.

Biohaven Ltd. operates as a biopharmaceutical firm actively engaged in clinical trials. Its primary objective is to advance innovative treatments for disorders affecting the nervous and immune systems, with the potential to transform current medical interventions.

Can you invest in Biohaven Ltd.?

Yes. Biohaven Ltd. trades publicly on NYSE as BHVN.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Biohaven Ltd.

Detailed equity research is provided by MarketSnap.